Hiv / Aids And Aids

Contracting Human Immunodeficiency Virus (HI Virus) in western civilization no longer means living in fear. While taking the medication, Highly Active Anti-Retroviral Therapy (HAART), the virus cannot be spread. Therefore allowing the patient to remain sexually active and procreate without passing on HI Virus to others. This treatment causes the HI Virus enter into a of hibernation phase, allowing the infected person to live a more normal life. Even though it sounds like a miracle drug, the geographical areas that are most affected by this virus are not being treated. This essay will discuss why this medication is not the final answer. How HAART is not available to the countries that need it most, and even though a true cure has been found,

According to the authors of Chapter 5, the single factor that explains the sharp drop in mortality in the U.S. was the introduction of Highly Active Antiretroviral Therapy (HAART) in 1996. HAART, medications including at least two different classes/kinds of ARVs, was found to suppress the virus and restore patients’ immune systems for sustained periods.

Since the outbreak of HIV/AIDS, an estimated 78 million people have acquired HIV and has killed approximately 39 million people infected with the virus. The prognosis of the epidemic has continued to vary from different countries and according to global statistics; 35 million people in 2013 were living with HIV/AIDS. 2.5 million People per annum acquire the virus and 1.5 million die of AIDS. Inspite of the drastic transmission of the HIV/AIDS epidemic, the development and accessibility of anti-retroviral drugs has decreased mortality rates by 22% from a population of 2.0million in 2009 to 1.5million in 2013 (WHO, 2013),

HIV, on the other hand, constitutes another major global public health issue. It is estimated that, so far, more than 34 million people have died from the disease(2,3). In 2014, 1.2 (980.000-1.6 million) million deaths were attributed to HIV-related causes(2). The most HIV-affected region is Sub-Saharan Africa, accounting for almost 70% of the global total of new HIV cases(2,4). In 2014, 25.8

The data was nationally collected to determine Sweden’s progress in reaching the 90-90-90 goal. By the end of 2015, Sweden had reached and surpassed the UN’s goal. They had 90% of cases diagnosed, 99.8% of people were linked to antiretroviral therapy and 95% of people taking antiretroviral for 6 months or more had a viral load below 50 copies/ml (Carter). The use of antiretroviral therapy in many patients who have HIV has reduced

The Human Immunodeficiency Virus or HIV as it is commonly known was first seen in the United States about thirty years ago before it generated the world 's attention. Since then thousands of American have lost their lives to AIDS and millions more have become infected. As a health organization, GA Carmichael has a growing population of patients infected with HIV. As the

Currently the best standard drug regimen available for HIV-1 infection is that of highly active retroviral treatment (HAART) (Scott & Tsevat, 2006). The dilemma is that in 2006, the estimated cost per year of HAART was $730 per person. This excludes the fact that market prices of HAART are typically higher, especially in the US. No country in Africa, and few countries elsewhere in the developing world can afford this level of treatment (Specter, 2003). Another interesting study in 2002 found that only 39 out of the 160 countries that data was collected had a per capita health expenditure over $730, which is startling. More so, 85 out of those 160 countries spent under $300 per capita in health expenditures (The Kaiser Family Foundation, 2002). Interestingly, another study conducted showed that in 2006, India's total per capita health expenditure amounted to $23 (Gupta & Bollinger, 2006). These studies truly suggest how unobtainable these HIV-1 treatments are to the developing countries. Ultimately, this further suggests that to provide trial participants with these optimal treatments, outside entities would be required for providing the funds.

Human immunodeficiency virus (HIV)/AIDS is a pandemic problem affecting global health. At the end of 2015, 36.7 million people were living with HIV/AIDS globally. The rate of incidence is more prevalent in Sub-Saharan Africa with almost 1 in every 24 adults living with HIV/AIDS. In the united states, HIV/AIDS is a diversified health problem affecting all sexes, ages and races and involving the transmission of multiple risk behavior. However, with the introduction of various prevention programs and antiretroviral drugs, the incidence of HIV/AIDS has reduced.

“The Human Immunodeficiency Virus, most commonly known as HIV, is a lentivirus that spreads through bodily fluids and targets specific in cells of the immune system” (CDC). Over time, HIV deteriorates these cells, and consequently leaves the body unable to fight off infections and disease. When this occurs, the HIV infection transgresses into Acquired Immunodeficiency Syndrome, also known as AIDS. AIDS continues to obliterate the immune system and leaves its victims more susceptible to opportunistic illnesses which utilize the body’s weakened state and cause more devastating illnesses. “According to the World Health Organization, HIV/AIDS are ranked as the 6th leading causes of death with a staggering 1.5 million deaths since 2012” (WHO). With this issue becoming an international crisis affecting millions, advocacy about HIV and safe sex has drastically increased around the globe due to humanitarian organizations, and increased awareness about the disease.

Since its outbreak the Human immunodeficiency virus (HIV) which goes on to develop in to Acquired immune deficiency syndrome (AIDS) has been reported in over 119 countries with 78 million people being infected resulting in over 39 million deaths. As of 2013 an estimated 0.8% of the world’s population aged 15-49 are living with HIV, this varies dramatically for individual countries with it rising to 71% in sub-Saharan Africa [ ]. This has lead to a dramatic decrease in life expectancy as shown in figure 1[ ]; this intern reduces the working population causing economical impacts. Recent recovery in life expectancy is due as a result in our increased understanding of how HIV replicates, allowing for the development of drugs that interrupts its

The discovery and implementation of antiretroviral therapy (ART) changed the prognosis for many with HIV from a fatal death sentence to a manageable chronic disease which enables sufferers to lead full lives. 96% of people living with HIV in the UK accessed ART treatment (Figure 2) in 2016.

The scaling up of ART follows the public health approach of using the standardized and simplified treatment regimens that are consistent with international standards (Bennett et al., 2012). However the treatment with ARV drugs can be accompanied by emergence and transmission of HIV DR. The emergence of HIV DR can limit the treatment options that will need switching to the second-line regimens that is costly and can produce long term toxicities (Bennett et al., 2012). In order to counter the effects of HIV DR, WHO developed a global strategy for the prevention and minimizing the emergence of HIV DR (Bennett et al., 2008, 2012). The WHO strategy involves three elements:

The number of individuals in South Africa infected with HIV is larger than in any other single country in the world. The 2007 UNAIDS report estimated that 5,700,000 South Africans had HIV/AIDS, or just under 12% of South Africa 's population of 48 million. In the adult population the rate is 18.5%.

Almost 36.9 million people are currently living with HIV infection and almost 10 million people being died from the infection or as a result related causes or opportunistic infections. At present people acquired the infection reported from all regions in the world. The majority of old and new cases are reported from sub-Saharan Africa which accounts for almost 70%. Most of the HIV infection affects people at their predictive life, and around 40% of the infection occurs in young youth at age less than 25 ys. (Global Health policy, 2014).

HIV infection has progressively become an epidemic disease, spreading virtually to all social classes. Every year, high new-infection rates are reported even